2nd Edition of International Cancer Research Conference
March 19-21, 2026 | Singapore
Cancer Prognosis
A disease's prognosis is an estimate of the disease's anticipated course and outcome. Cancer prognosis usually refers to the likelihood of recovery and success with treatment. Many things can influence a cancer patient's prognosis. The type and location of the cancer, the cancer stage (the extent to which the cancer has spread throughout the body), and the cancer's grade (how abnormal the cancer cells appear under a microscope—an indicator of how quickly the cancer is likely to grow and spread) are among the most important factors. After taking into account the factors that influence prognosis, a patient's expected five-year survival is computed. This incorporates all elements such as available treatment options and other health issues that could affect the disease's successful treatment.
- Factors affecting prognosis
- Biomarkers and prognosis
- Depicting cancer prognosis
Rajvir Dahiya
University of California San Francisco, United States
Anyou Wang
DIFIBER LLC, United States
Michael Thompson
University of Toronto, Canada
Can Küçük
Dokuz Eylul University, Turkey
Nadia Leney Olazo Marquez
Benemérita Universidad Autónoma de Puebla, Mexico
Liu Ying
Shanghai University, China
Ratan Kumar Sarkar
Independent Researcher, IndiaSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : A case-based approach using IMPeTUs criteria in FDG PET/CT reporting of multiple myeloma
Mudalsha Ravina, All India Institute of Medical Sciences, India
Title : Transforming cancer care: Innovations, integrations, and impact
Shayan Maqsood, Jamia Hamdard University, India
Title : Updates on controversies surrounding the staging and management of newly diagnosed localized prostate cancer using prostate-specific membrane antigen (PSMA) positron emission tomography
Patricia Tai, University of Saskatchewan, Canada
Title : Advanced nanoparticles, the hallmark of targeted drug delivery for osteosarcoma
Shayan Maqsood, Jamia Hamdard University, India